Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Plotkin

Showing results (281-290 of 474) with videos related to

Pageof 48
Sort By:
JAMA|August 6, 1973
Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United StatesS A Plotkin, J D Farquhar, P L Ogra
Nature Immunology|June 19, 2014
Toward a human vaccines projectWayne C Koff, Ian D Gust, Stanley A Plotkin
Lancet (London, England)|February 21, 1987
AIDS in a child without antibody to HIVG S Marshall, S D Barbour, S A Plotkin
JAMA Pediatrics|March 2, 2026
A Vaccine to Prevent Congenital Cytomegalovirus: Where Do We Go Next?Mark R Schleiss, Stanley A Plotkin, Sallie R Permar
Plos Pathogens|May 4, 2026
Why do we have a vaccine for measles, but not cytomegalovirus (CMV)?Mark R Schleiss, Sallie R Permar, Stanley A Plotkin
Immunological Reviews|June 6, 2022
Correlates of protection against SARS-CoV-2 infection and COVID-19 diseaseDavid Goldblatt, Galit Alter, Shane Crotty, et al.
Journal of Virology|July 19, 2018
Reply to Gantt et al., "Higher Expectations for a Vaccine To Prevent Congenital Cytomegalovirus Infection"Sallie R Permar, Mark R Schleiss, Stanley A Plotkin
Vaccine|March 2, 2022
The scourge of vaccine falsificationPierre Saliou, Quentin Duteil, Stanley A Plotkin, et al.
Journal of Virological Methods|August 1, 1986
A rapid microneutralization assay for cytomegalovirusE Gonczol, G Furlini, J Ianacone, et al.
The New England Journal of Medicine|October 8, 1970
Herpetic paronychia--an occupational hazard of medical personnelF E Rosato, E F Rosato, S A Plotkin
Pageof 48

Showing results (281-290 of 474) with videos related to

Sort By:
Pageof 48
JAMA|August 6, 1973
Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United StatesS A Plotkin, J D Farquhar, P L Ogra
Nature Immunology|June 19, 2014
Toward a human vaccines projectWayne C Koff, Ian D Gust, Stanley A Plotkin
Lancet (London, England)|February 21, 1987
AIDS in a child without antibody to HIVG S Marshall, S D Barbour, S A Plotkin
JAMA Pediatrics|March 2, 2026
A Vaccine to Prevent Congenital Cytomegalovirus: Where Do We Go Next?Mark R Schleiss, Stanley A Plotkin, Sallie R Permar
Plos Pathogens|May 4, 2026
Why do we have a vaccine for measles, but not cytomegalovirus (CMV)?Mark R Schleiss, Sallie R Permar, Stanley A Plotkin
Immunological Reviews|June 6, 2022
Correlates of protection against SARS-CoV-2 infection and COVID-19 diseaseDavid Goldblatt, Galit Alter, Shane Crotty, et al.
Journal of Virology|July 19, 2018
Reply to Gantt et al., "Higher Expectations for a Vaccine To Prevent Congenital Cytomegalovirus Infection"Sallie R Permar, Mark R Schleiss, Stanley A Plotkin
Vaccine|March 2, 2022
The scourge of vaccine falsificationPierre Saliou, Quentin Duteil, Stanley A Plotkin, et al.
Journal of Virological Methods|August 1, 1986
A rapid microneutralization assay for cytomegalovirusE Gonczol, G Furlini, J Ianacone, et al.
The New England Journal of Medicine|October 8, 1970
Herpetic paronychia--an occupational hazard of medical personnelF E Rosato, E F Rosato, S A Plotkin
Pageof 48